The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD) (2017)
- Authors:
- USP affiliated authors: KUBO, CHRISTINA ARSLANIAN - ICB ; CONDINO NETO, ANTONIO - ICB ; ZURRO, NURIA BENGALA - ICB
- Unidade: ICB
- DOI: 10.1007/s10875-017-0442-2
- Subjects: IMUNOLOGIA; INFECÇÕES BACTERIANAS; MACRÓFAGOS; LINFÓCITOS
- Language: Inglês
- Imprenta:
- Publisher: Springer New York LLC
- Publisher place: New York
- Date published: 2017
- Source:
- Título: Journal of Clinical Immunology
- ISSN: 1573-2592
- Volume/Número/Paginação/Ano: v. 37, Supl. 1, p. S31, res. PO-084, 2017
- Conference titles: 2017 LASID Meeting Abstracts
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ZURRO, Nuria Bengala e KUBO, Christina Arslanian e CONDINO-NETO, Antonio. The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD). Journal of Clinical Immunology. New York: Springer New York LLC. Disponível em: https://doi.org/10.1007/s10875-017-0442-2. Acesso em: 31 mar. 2026. , 2017 -
APA
Zurro, N. B., Kubo, C. A., & Condino-Neto, A. (2017). The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD). Journal of Clinical Immunology. New York: Springer New York LLC. doi:10.1007/s10875-017-0442-2 -
NLM
Zurro NB, Kubo CA, Condino-Neto A. The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD) [Internet]. Journal of Clinical Immunology. 2017 ; 37 S31.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1007/s10875-017-0442-2 -
Vancouver
Zurro NB, Kubo CA, Condino-Neto A. The use of the Lysate of mycobacterial (LM) and purified protein (PPD) to the diagnosis of patients with mendelian susceptibility to mycobacterial disease (MSMD) [Internet]. Journal of Clinical Immunology. 2017 ; 37 S31.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1007/s10875-017-0442-2 - Chronic granulomatous disease in a brazilian patient mimetizing sarcoidosis
- BAY 41-2272 activates host defence against local and disseminated Candida albicans infections
- Leukocytes from wheezing infants release lower amounts of IL-12 and IFN-γ compared to non-wheezing infants
- BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes
- Peripheral blood mononuclear cells from severe asthmatic children release lower amounts of IL-12 and IL-4 after LPS stimulation
- A novel mutation in the NCF2 gene in a CGD patient with chronic recurrent pneumopathy
- A novel mutation in CYBB gene in a patient with chronic colitis and recurrent pneumonia due to X‐linked chronic granulomatous disease
- A C126R de novo mutation in CYBB Leads to X-linked chronic granulomatous disease with recurrent pneumonia and BCGitis
- The role of M. leprae Hsp65 protein and peptides in the pathogenesis of uveitis
- Caracterização clínica e genética de pacientes brasileiros com doença granulomatosa crônica e susceptibilidade mendeliana a infecções por micobactérias
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
